Hepatitis Treatment at The Liver Institute

Viral hepatitis is a silent disease that can lead to liver fibrosis, cirrhosis, and cancer. The Liver Institute has been on the forefront of treatment of viral hepatitis B and C for over 15 years. Through groundbreaking therapies and comprehensive management strategies, we are able to effectively cure a vast majority of patients and prevent further complications.

Hepatitis C effects about 3 million American and is the most common cause of liver cancer in the United states. The disease can often go undiagnosed due to lack of symptoms. With effective screening strategies, especially for patients born between 1945-1965, we can capture patients at an earlier stage and provide treatment before complications arise.

Hepatitis B effects about 1.5 million and is more common among those coming from Asian, sub Africa and the far East. With effective treat and cancer screening strategies, we can mitigate the complications experienced with this disease.